WASHINGTON, Sept. 26, 2019 /PRNewswire/ -- Fitbit and Apple Watch both excel in brand recognition in the wearable market, according to

MILAN, Sept. 26, 2019 /PRNewswire/ -- Newronika, a spin-off of world-class neurological research centers Policlinico of Milan and University of Milan, has raised an 8.4 million Euros Series-A round. The investment was led by French venture capital fund Omnes together with existing investors Innog

Multi-State, Vertically Integrated Cannabis Company to Open Second Dispensary in Commonwealth PHOENIX, Sept. 26, 2019 /PRNewswire/ -- Harvest Health & Recrea

SAN FRANCISCO, Sept. 26, 2019 /PRNewswire/ --– InsightRX, a pioneer in precision medicine, is pleased to announce the addition of Dunnie Norman as Senior Vice Preside

NORTH HOLLYWOOD, Calif., Sept. 26, 2019 /PRNewswire/ -- ConsejoSano, the multicultural patient engagement platform for payers, providers, and health systems, will hold its first annual conf

LOS ALTOS, Calif., Sept. 26, 2019 /PRNewswire/ -- GenomeSmart, a Silicon Valley-based company delivering the first AI-powered genetic risk assessment and test recommendation platform that simplifies and reduces the burden of providing genetic assessment at scale, today announced the availability of GenoWatchTM, a population-level dashboard and new feature for

RENO, Nev., Sept. 26, 2019 /PRNewswire/ -- Frank Morese, CEO and CTO of Olea Sensor Networks, will speak at this year's Telehealth Secrets Conference in Silicon Valley, October 2-4 addressing the benefits of machine learning diagnostic technologies for medical applications. His topic, Reviving the Family Doc

NEW YORK, Sept. 26, 2019 /PRNewswire/ -- The US Navy Veterans Mesothelioma Advocate says, "We are appealing to a US Navy Veteran or a shipyard worker who has recently

SAN RAFAEL, Calif., Sept. 26, 2019 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN), a pioneer in treatments for rare disease Phenylketonuria (PKU) and in gene therapies, today announced that it has submitted a Clinical Trial Application (CTA) with the Medicines and Healthcare Products Regulatory Agency (MHRA) in the U.K. for BMN 307, an investigational AAV5-ph

BRANFORD, Conn., Sept. 26, 2019 /PRNewswire/ -- IsoPlexis, the leader in single-cell functional proteomics, continues to build upon recent success in the CAR-T field through NCI funding, advanced cell therapy data sets, and with the release of a co-marketing Tech Note with Miltenyi Biotec, Inc.